Synergy Biomed Research Institute (SBRI)
About Synergy Biomed Research Institute (SBRI)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Gilead Sciences
1
Janssen Vaccines & Prevention B.V.
1
Clinical Trials at Synergy Biomed Research Institute (SBRI)
During the past decade, Synergy Biomed Research Institute (SBRI) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older
2021-07-21
2024-11-18
Recruiting
27,200
Pre-Exposure Prophylaxis Study of Lenacapavir and Emtricitabine/Tenofovir Alafenamide in Adolescent Girls and Young Women at Risk of HIV Infection
2021-08-30
2027-07-01
Recruiting
5,010
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Synergy Biomed Research Institute (SBRI)
According to Clinical.Site data, the most researched conditions in "Synergy Biomed Research Institute (SBRI)" are
"Lower Respiratory Tract Disease" (1 trials), "Pre-Exposure Prophylaxis of HIV Infection" (1 trials) and "Respiratory Syncytial Viruses" (1 trials). Many other conditions were trialed in "Synergy Biomed Research Institute (SBRI)" in a lesser frequency.
Clinical Trials Intervention Types at Synergy Biomed Research Institute (SBRI)
Most popular intervention types in "Synergy Biomed Research Institute (SBRI)" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Adenovirus serotype 26 (Ad26)-based respiratory syncytial virus (RSV). preF" (1 trials), "F/TAF" (1 trials), "F/TDF" (1 trials), "Oral Lenacapavir (LEN)" (1 trials) and "PTM F/TAF" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Synergy Biomed Research Institute (SBRI)
The vast majority of trials in "Synergy Biomed Research Institute (SBRI)" are
1 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Synergy Biomed Research Institute (SBRI)
Currently, there are NaN active trials in "Synergy Biomed Research Institute (SBRI)".
undefined are not yet recruiting,
2 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Synergy Biomed Research Institute (SBRI),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Synergy Biomed Research Institute (SBRI), 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".